公告
Change - Announcement Of Cessation Of Independent Director
BackApr 15, 2024
| Announcement Title | Change - Announcement of Cessation |
| Date & Time of Broadcast | Apr 15, 2024 0:05 |
| Status | New |
| Announcement Sub Title | CESSATION OF INDEPENDENT DIRECTOR |
| Announcement Reference | SG240415OTHRQJRU |
| Submitted By (Co./ Ind. Name) | Lim Kuoh Yang |
| Designation | Chief Executive Officer |
| Description (Please provide a detailed description of the event in the box below) | Cessation of Independent Director - Gan Siew Lian This announcement has been reviewed by the Company's Sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "Exchange") and the Exchange assumes no responsibility for the contents of this document, including the correctness of any of the statements or opinions made or reports contained in this document. The contact person for the Sponsor is Ms Lim Hui Ling, 16 Collyer Quay, #10-00 Collyer Quay Centre, Singapore 049318, sponsorship@ppcf.com.sg |
| Additional Details | |
| Name Of Person | Gan Siew Lian |
| Age | 58 |
| Is effective date of cessation known? | Yes |
| If yes, please provide the date | 30/04/2024 |
| Detailed Reason (s) for cessation | Dr Gan Siew Lian ("Dr Gan") has served on the Board of Directors (the "Board") for more than nine years since her appointment as Director of the Company. As part of the Board renewal process, Dr Gan will be retiring as Director at the conclusion of the Company's annual general meeting scheduled to be held on 30 April 2024 (the "AGM"). Dr Gan, upon her retirement, will relinquish her roles as Independent Director, Chairperson of the Nominating Committee and member of the Audit and Remuneration Committees. After having interviewed Dr Gan and to the best of its knowledge, the Company's Sponsor, PrimePartners Corporate Finance Pte. Ltd., is satisfied that, other than as disclosed in this announcement, there are no other material reasons for the retirement of Dr Gan as Independent Director of the Company. The Board and Management would like to thank Dr Gan for her invaluable contribution during her tenure with the Company. |
| Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting? | No |
| Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer? | No |
| Any other relevant information to be provided to shareholders of the listed issuer? | No |
| Date of Appointment to current position | 01/07/2012 |
| Does the AC have a minimum of 3 members (taking into account this cessation)? | No |
| Number of Independent Directors currently resident in Singapore (taking into account this cessation) | 0 |
| Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months | 2 |
| Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) | Independent Director, Chairperson of the Nominating Committee and member of the Audit Committee and Remuneration Committees. |
| Role and responsibilities | Independent Director, Chairperson of the Nominating Committee and member of the Audit Committee and Remuneration Committees. |
| Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries | Nil |
| Shareholding interest in the listed issuer and its subsidiaries? | No |
| Past (for the last 5 years) | Nil |
| Present | Nil |